Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $36.73 billion. The enterprise value is $37.63 billion.
| Market Cap | 36.73B |
| Enterprise Value | 37.63B |
Important Dates
The last earnings date was Tuesday, October 28, 2025, before market open.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | Aug 28, 2025 |
Share Statistics
Xylem has 243.47 million shares outstanding. The number of shares has increased by 0.28% in one year.
| Current Share Class | 243.47M |
| Shares Outstanding | 243.47M |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 94.20% |
| Float | 241.81M |
Valuation Ratios
The trailing PE ratio is 38.89 and the forward PE ratio is 27.80. Xylem's PEG ratio is 2.18.
| PE Ratio | 38.89 |
| Forward PE | 27.80 |
| PS Ratio | 4.13 |
| Forward PS | 3.93 |
| PB Ratio | 3.28 |
| P/TBV Ratio | 60.41 |
| P/FCF Ratio | 41.36 |
| P/OCF Ratio | 28.85 |
| PEG Ratio | 2.18 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.29, with an EV/FCF ratio of 42.37.
| EV / Earnings | 39.69 |
| EV / Sales | 4.23 |
| EV / EBITDA | 20.29 |
| EV / EBIT | 29.39 |
| EV / FCF | 42.37 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.96 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 1.04 |
| Debt / FCF | 2.35 |
| Interest Coverage | 40.00 |
Financial Efficiency
Return on equity (ROE) is 8.56% and return on invested capital (ROIC) is 6.10%.
| Return on Equity (ROE) | 8.56% |
| Return on Assets (ROA) | 4.80% |
| Return on Invested Capital (ROIC) | 6.10% |
| Return on Capital Employed (ROCE) | 8.52% |
| Revenue Per Employee | $386,696 |
| Profits Per Employee | $41,217 |
| Employee Count | 23,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 5.17 |
Taxes
In the past 12 months, Xylem has paid $245.00 million in taxes.
| Income Tax | 245.00M |
| Effective Tax Rate | 20.62% |
Stock Price Statistics
The stock price has increased by +15.84% in the last 52 weeks. The beta is 1.13, so Xylem's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +15.84% |
| 50-Day Moving Average | 144.76 |
| 200-Day Moving Average | 130.91 |
| Relative Strength Index (RSI) | 61.73 |
| Average Volume (20 Days) | 1,186,446 |
Short Selling Information
The latest short interest is 2.68 million, so 1.10% of the outstanding shares have been sold short.
| Short Interest | 2.68M |
| Short Previous Month | 2.91M |
| Short % of Shares Out | 1.10% |
| Short % of Float | 1.11% |
| Short Ratio (days to cover) | 2.25 |
Income Statement
In the last 12 months, Xylem had revenue of $8.89 billion and earned $948.00 million in profits. Earnings per share was $3.88.
| Revenue | 8.89B |
| Gross Profit | 3.40B |
| Operating Income | 1.28B |
| Pretax Income | 1.19B |
| Net Income | 948.00M |
| EBITDA | 1.85B |
| EBIT | 1.28B |
| Earnings Per Share (EPS) | $3.88 |
Balance Sheet
The company has $1.19 billion in cash and $2.09 billion in debt, giving a net cash position of -$898.00 million or -$3.69 per share.
| Cash & Cash Equivalents | 1.19B |
| Total Debt | 2.09B |
| Net Cash | -898.00M |
| Net Cash Per Share | -$3.69 |
| Equity (Book Value) | 11.45B |
| Book Value Per Share | 46.02 |
| Working Capital | 2.17B |
Cash Flow
In the last 12 months, operating cash flow was $1.27 billion and capital expenditures -$385.00 million, giving a free cash flow of $888.00 million.
| Operating Cash Flow | 1.27B |
| Capital Expenditures | -385.00M |
| Free Cash Flow | 888.00M |
| FCF Per Share | $3.65 |
Margins
Gross margin is 38.23%, with operating and profit margins of 14.39% and 10.66%.
| Gross Margin | 38.23% |
| Operating Margin | 14.39% |
| Pretax Margin | 13.36% |
| Profit Margin | 10.66% |
| EBITDA Margin | 20.85% |
| EBIT Margin | 14.39% |
| FCF Margin | 9.98% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 1.06%.
| Dividend Per Share | $1.60 |
| Dividend Yield | 1.06% |
| Dividend Growth (YoY) | 10.64% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 40.21% |
| Buyback Yield | -0.28% |
| Shareholder Yield | 0.78% |
| Earnings Yield | 2.58% |
| FCF Yield | 2.42% |
Analyst Forecast
The average price target for Xylem is $160.00, which is 6.07% higher than the current price. The consensus rating is "Buy".
| Price Target | $160.00 |
| Price Target Difference | 6.07% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 5.59% |
| EPS Growth Forecast (5Y) | 14.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.37 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.37 |
| Piotroski F-Score | 8 |